1. The “red herring” after 20 years: ageing and health care expenditures

   • Friedrich Breyer
   • Normann Lorenz

   Editorial Open access 04 June 2020 Pages: 661 - 667

2. A cost-effectiveness analysis of pembrolizumab with or without chemotherapy for the treatment of patients with metastatic, non-squamous non-small cell lung cancer and high PD-L1 expression in Switzerland

   • Michaela Carla Barbier
   • Esther Pardo
   • for the Swiss Group for Clinical Cancer Research (SAKK)

   Original Paper Open access 21 March 2021 Pages: 669 - 677

   

3. Trust me; I know what I am doing investigating the effect of choice list elicitation and domain-relevant training on preference reversals in decision making for others

   • Sebastian Neumann-Böhme
   • Stefan A. Lipman
   • Arthur E. Attema

   Original Paper Open access 20 March 2021 Pages: 679 - 697

   

4. How Managed Entry Agreements can improve allocation in the public health system: a mechanism design approach

   • Shuli Brammli-Greenberg
   • Ira Yaari
   • Ariella Adijes-Toren

   Original Paper 23 March 2021 Pages: 699 - 709

   

5. Cost-effectiveness of adding Sativex® spray to spasticity care in Belgium: using bootstrapping instead of Monte Carlo simulation for probabilistic sensitivity analyses

   • Mark Oppe
   • Daniela Ortín-Sulbarán
   • Juan M. Ramos-Goñi

   Original Paper Open access 20 April 2021 Pages: 711 - 721

   

6. Evaluating the conduct and application of health utility studies: a review of critical appraisal tools and reporting checklists

   • Michael J. Zoratti
   • A. Simon Pickard
   • Health Utility Book (HUB) Working Group

   Original Paper 11 April 2021 Pages: 723 - 733

   

7. Mapping PedsQL™ Generic Core Scales to EQ-5D-3L utility scores in transfusion-dependent thalassemia patients

   • Asrul Akmal Shafie
   • Irwinder Kaur Chhabra
   • Noor Syahireen Mohammed

   Original Paper 15 April 2021 Pages: 735 - 747

   

8. Are long-term care jobs harmful? Evidence from Germany

   • Thomas Rapp
   • Jérôme Ronchetti
   • Jonathan Sicsic

   Original Paper 11 April 2021 Pages: 749 - 771

   

9. Bayesian modeling of health state preferences: could borrowing strength from existing countries’ valuations produce better estimates

   • Samer A. Kharroubi
   • Yara Beyh

   Original Paper 24 March 2021 Pages: 773 - 788

   

10. Has the development of cancer biomarkers to guide treatment improved health outcomes?

    • Ana Beatriz D′Avó Luís
    • Mikyung Kelly Seo

    Original Paper Open access 30 March 2021 Pages: 789 - 810

    

11. Risky business, healthy lives: how risk perception, risk preferences and information influence consumer’s risky health choices

    • Jean Spinks
    • Son Nghiem
    • Joshua Byrnes

    Original Paper 10 April 2021 Pages: 811 - 831

    

12. The impact of nurse staffing levels on nursing-sensitive patient outcomes: a multilevel regression approach

    • Karina Dietermann
    • Vera Winter
    • Jonas Schreyögg

    Original Paper Open access 19 April 2021 Pages: 833 - 846

13. Correction to: A general framework for classifying costing methods for economic evaluation of health care

    • Zuzana Špacírová
    • David Epstein
    • Jaime Espín

    Correction Open access 25 May 2021 Pages: 847 - 847

14. Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease

    • L. M. Peña-Longobardo
    • B. Rodríguez-Sánchez
    • J. López-Bastida

    Correction Open access 25 May 2021 Pages: 849 - 849